urge, I'm surprised you divested at such low price levels?
I certainly understand and share your frustration with so little communication from management. The company is basically two doctors and an accountant, everything else is outsourced. They are literally the anti-pump and dump company.
I believe they believe in their science and I'm guessing they see it as largely binary (sure there are other trials in development) and thus, success will result in a sharp correction and failure will be what it will be. The history with Alzheimers drugs is that pretty much every one fails and then class action shareholder lawsuits trigger forcing the defending of all communications. This team must feel that less is more in the long run...
I'm fine with this stock being artificially low (obviously my opinion but this thing should be above $10 at a minimum), as long as there is no dilutive equity offering at these prices... The company doesn't need it right now and should get the results before deciding on steps such as this, IMHO...
Keep the faith!!!
News 
Market Data 
Discover 
